Rare Disease Research is a biotechnology company dedicated to developing treatments for rare and orphan diseases, focusing on conditions that affect a small percentage of the population. They generate revenue through the development and commercialization of specialized therapies, often collaborating with academic institutions and leveraging grants and partnerships. Founded in the early 2000s, the company has a history of pioneering innovative treatments, with several products successfully reaching the market, significantly impacting patient care in niche medical fields.